Name: EW Income Statement - Edwards Lifesciences Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

EW - Edwards Lifesciences Corp.

USD | NYSE | Healthcare

EW Income Statement - Edwards Lifesciences Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	1,648.6	1,569.6	1,553.1	1,532.2	1,412.7	1,385.8	1,354.4	1,369.4	1,329.9	1,011.5	1,243.4	1,295.5	1,459.6	429.9	1,319.0	1,373.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	6,303.5	6,067.6	5,439.5	5,010.0	4,464.0	5,232.5	4,386.3	4,348.0	3,722.8	3,435.3	2,963.7	2,493.7	2,322.9	2,045.5	1,899.6	1,678.6	1,447.0	1,321.4
Cost of Revenue	1,395.2	1,334.2	1,117.5	978.4	723.7	1,248.9	1,080.6	1,114.4	939.4	875.3	797.4	617.2	625.6	516.6	491.0	489.8	408.3	399.1
Gross Profit	4,908.3	4,733.4	4,322.0	4,031.6	3,740.3	3,983.6	3,305.7	3,233.6	2,783.4	2,560.0	2,166.3	1,876.5	1,697.3	1,528.9	1,408.6	1,188.8
Operating Expenses
Research & Development	1,087.9	1,079.2	1,053.0	962.9	843.6	903.1	760.7	752.7	622.2	552.6	442.2	382.9	346.5	323.0	291.3
Operating Income
Operating Income	1,347.0	1,264.2	1,378.7	1,308.9	1,498.4	1,690.3	897.6	1,146.8	748.2	1,089.4	751.2	-	-	-
Non-Operating
Interest Income	-	168.8	120.3	67.2	35.5	17.4	23.4	32.2	32.0	20.3	10.8	7.9	6.4	4.6	4.8
Tax & Net
Income Tax Expense	224.9	216.9	152.1	152.4	195.5	198.9	93.3	119.6	39.2	451.3	168.4	127.5	332.9	122.1	96.7
Per Share
EPS Basic	1.89	1.84	6.98	2.31	2.46	2.41	1.32	1.68	1.15	2.77	2.67	2.30	3.81	1.74	2.54	2.07
Supplementary Data
EBITDA	-	1,420.8	1,533.9	1,453.8	1,638.0	1,825.1	1,004.8	1,236.1	825.6	1,171.3	822.4	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	263.3	267.7	280.7	276.2	254.6	271.1	253.4	271.8	256.7	215.2	242.8	243.7	261.2	130.6	233.6	250.8	228.6	232.8	238.0	225.3	207.0	195.7	195.5	182.1	187.4	193.9	195.5	191.9	171.4	163.1	161.8	154.1	143.2	146.6	142.9	134.4	128.7	114.9	113.0	112.5
Selling General & Administrative	522.2	602.9	514.6	502.0	465.7	491.9	421.4	447.5	428.4	353.9	381.9	410.4	436.3	201.0	377.3	409.0
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	40.9	-	-	-	36.6	-	-	-	38.5	-	-	-	35.2	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	14.2	14.3	12.5	21.3	19.1	22.7	(22.4)	0.0	0.0	-	0.0	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	477.6	151.1	307.1	411.2	394.8	312.6	350.6	366.5	349.0	291.1	365.9	263.5	388.4	197.7	402.4	459.5	438.8	374.4	390.3	542.1	383.5	351.4	357.8	(169.7)	358.1	310.8	294.3	267.5	274.2	(5.3)	248.9	252.1	252.5	336.1	214.0	241.0	298.3	-	-	-

Non-Operating
Interest Income	33.5	-	-	-	36.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(18.6)	(60.7)	41.3	(11.0)	39.1	77.5	52.2	17.5	22.2	52.8	6.6	2.5	1.6	22.1	(2.0)	4.3	(3.3)
Pre-Tax Income	459.0	90.4	348.4	400.2	433.9	390.1	402.8	384.0	371.2	311.1	387.6	275.1	398.6	211.4	407.3	464.7

Tax & Net
Income Tax Expense	78.3	26.2	56.1	64.3	70.3	45.1	40.7	20.0	46.3	20.7	52.7	20.9	58.1	10.9	63.8	58.3	62.5	41.0	50.8	56.0	51.1	46.6	39.1	(46.3)	53.9	35.3	27.0	29.0	28.3	(8.8)	22.8	(31.7)	56.9	326.7	41.7	19.5	63.4	41.9	43.8	42.4
Net Income From Continuing Ops	380.7	64.2	292.3	335.9	363.6	345.0	362.1	364.0	324.9	290.4	334.9	254.2	340.5	200.5	343.5	406.4	373.6
Net Income From Discontinued Ops	0.0	27.0	(2.0)	(4.4)	(7.2)	39.3	2,707.3	1.0	26.1	-	48.8	51.3	-	-	-	-	-
Net Income	380.7	91.2	290.3	331.5	356.4	384.3	3,069.4	365.0	351.0	369.7	383.7	305.5	340.5	398.4	343.5	406.4	373.6
Net Income Attributable To Parent	380.7	91.2	291.1	333.2	358.0	385.6	3,070.8	366.3	351.9	369.9	384.9	307.1	340.5	398.4	343.5	406.4
Less: Minority Interest	0.0	0.0	(0.8)	(1.7)	(1.6)	(1.3)	(1.4)	(1.3)	(0.9)	(0.2)	(1.2)	(1.6)	0.0	-	0.0	0.0	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	380.7	91.2	291.1	333.2	358.0	385.6	3,070.8	366.3	351.9	369.9	384.9	307.1	340.5	398.4	343.5

Per Share
EPS Basic	0.66	-	0.50	0.57	0.61	-	5.14	0.61	0.58	-	0.63	0.51	0.56	-	0.55	0.65	0.60	-	0.55	0.79	0.54	-	0.52	(0.20)	0.50	-	0.44	0.39	1.20	-	1.08	1.35	0.98	-	0.81	0.88	1.09	-	0.66	0.60
EPS Diluted	0.66	-	0.50	0.56	0.61	-	5.13	0.61	0.58	-	0.63	0.50	0.56	-	0.55	0.65	0.59	-
Shares Basic	579.2	-	584.7	587.0	586.9	-	597.2	602.1	601.6	-	607.0	606.9	607.5	-	619.8	620.9	622.1	-
Shares Diluted	580.7	-	585.7	587.9	587.8	-	598.1	604.3	604.1	-	609.5	610.3	610.9	-	624.5	626.7	629.4	-

Supplementary Data
EBITDA	518.5	-	-	-	431.4	-	-	-	387.5	-	-	-	423.6	-	-	-	473.5	-	-	-	415.9	-	-	-	382.6	-	-	-	294.8	-	-	-	271.6	-	-	-	319.4	-	-	-
EBIT	477.6	151.1	307.1	411.2	394.8	312.6	350.6	366.5	349.0	291.1	365.9	263.5	388.4	197.7	402.4	459.5	438.8	374.4	390.3